Dystrophinopathy and the brain: A parent project muscular dystrophy (PPMD) meeting report November 11-12, 2021, New York City, NY

•Dystrophinopathies entail increased risk of neurodevelopmental and psychiatric conditions.•Ongoing research is needed to understand the role of dystrophin in brain development.•Clinical care should include screening for developmental delays and neuropsychiatric symptoms.•Comprehensive assessment and intervention to support brain and emotional health is critical.